Blueberry and ginseng buccal tablet capable of protecting eyes and resisting fatigue and preparation method of blueberry and ginseng buccal tablet
By scientifically combining blueberry powder, ginseng saponin extract, rohan saponin extract and other ingredients, combined with advanced technology, the problem of eye protection lozenges is poor in eye protection and insufficient stability in eye protection, and excellent eye protection is achieved Effect and stability ensure high quality and safety of the product.
Patent Information
- Application Number
- CN202411237388.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-26
AI Technical Summary
The existing eye protection lozenges have poor anti-fatigue effect and poor stability in eye protection, and do not achieve the best effect in the distribution ratio. They are insufficient in stability when temperature and humidity change, and are prone to moisture and deterioration.
The oral lozenges are prepared by enzymatic decomposition, pressing, double-effect concentration and freezing vacuum drying technology, combined with alcohol and water extraction technology, and scientifically matched Ingredients to form synergistic effects, hydroxypropyl methylcellulose is added to improve taste and stability.
实现了卓越的护眼效果,显著缓解眼部疲劳,改善视力,增强抗疲劳能力,提高了产品的稳定性和可压性,确保了高品质和高纯度的成品,避免了单一成分的副作用, In line with the pursuit of modern healthy eating.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of buccal tablets, and particularly relates to an eye-protecting and anti-fatigue blueberry ginseng buccal tablet and a preparation method thereof. Background Art
[0002] Eye protection lozenges are compressed tablets containing ingredients that are beneficial to the eyes (such as lutein, vitamins, minerals, plant extracts, etc.). These ingredients slowly dissolve in the mouth, are absorbed into the blood through the oral mucosa, and then have a protective effect on the eyes. Eye protection lozenges are mainly used to relieve eye fatigue, improve vision, and prevent eye diseases.
[0003] Eye protection lozenges usually contain a variety of ingredients that are beneficial to the eyes, such as lutein (a powerful antioxidant that can protect the retina from free radical damage), vitamins (such as vitamins A, C, E, etc., which are essential for eye health), minerals (such as zinc, selenium, etc., which help maintain normal eye function) and specific plant extracts (such as blueberry extract, cassia seed extract, etc., which have antioxidant and anti-inflammatory effects).
[0004] Currently, eye protection lozenges only focus on a certain type of ingredients that are beneficial to the eyes, such as lutein or vitamins, while ignoring other equally important ingredients. In addition, the ratio between different ingredients does not achieve the best effect, and excessive or insufficient intake may affect the overall effect of the product. For example, the intake of lutein needs to be controlled within a certain range, and excessive intake may put a burden on the liver.
[0005] Generally speaking, eye lozenges should be stored in a cool, dry, ventilated place away from direct sunlight. The specific temperature range may vary depending on the product, but it is generally recommended to store it at room temperature, that is, between 10°C and 30°C. Eye lozenges also have certain requirements for humidity and should be stored in an environment with appropriate relative humidity to avoid excessive humidity that may cause the product to become damp and deteriorate. Since the ingredients in some eye lozenges may be sensitive to light, they should be avoided from prolonged exposure to strong light and should preferably be stored in a light-proof container. However, temperature changes are inevitable during the transportation and storage of eye lozenges, such as changes between extremely high temperatures and extremely high temperatures, which puts forward new requirements for the stability of eye lozenges. Summary of the invention
[0006] The purpose of the present invention is to provide an eye-protecting and anti-fatigue blueberry ginseng buccal tablet and a preparation method thereof, so as to solve the problems that the above-mentioned eye-protecting buccal tablet has poor eye-protecting and anti-fatigue effects and poor stability of the buccal tablet.
[0007] To achieve the above-mentioned object, the first aspect of the present invention provides a blueberry ginseng buccal tablet for eye protection and anti-fatigue, wherein the buccal tablet comprises the following raw materials in terms of mass percentage: Blueberry powder 30~50% Ginsenoside extract 20~30% Momordica Saponin Extract 5~10% Magnesium stearate 2~5% Hydroxypropyl methylcellulose 15~25%.
[0008] Preferably, the method for preparing blueberry powder comprises the following steps: S11: Selection of blueberry varieties Select the garden blueberry variety with the highest anthocyanin content as the raw material; S12: Enzymatic hydrolysis Fresh blueberries are crushed by roller squeezing, and then pectinase and cellulase are added for enzymatic hydrolysis at room temperature. S13: Squeeze After the enzymatic hydrolysis is completed, the blueberry juice is squeezed by using an air bag squeezer to obtain blueberry juice; S14: Concentrated The blueberry juice is concentrated by using double-effect concentration technology to obtain blueberry concentrated juice; S15: Dry The blueberry concentrate is dried into blueberry fruit powder using freeze vacuum drying technology.
[0009] Preferably, the method for preparing the ginsenoside extract comprises the following steps: S21: cutting the fresh ginseng into ginseng slices with a thickness of 1-3 mm using a slicer; S22: Put the ginseng slices into an extraction tank, add alcohol to extract the ginseng slices for the first time, and obtain an extract. After the extract is filtered through a 200-mesh filter, it is pumped into a double-effect concentration tank, and the ginseng slices are again added with alcohol for a second extraction. The secondary extracts are combined and concentrated to obtain a ginsenoside extract. The concentration of the ginsenoside extract is 10-15 g / kg.
[0010] Preferably, the preparation method of the mogroside extract comprises the following steps: S31: crushing the dried monk fruit to obtain coarse powder; S32: adding the coarse powder to an extraction tank, adding water to the extraction tank for the first extraction, filtering the extract through a 200-mesh filter and pumping it into a double-effect concentration tank, adding water to the extraction tank for the second extraction, combining the secondary extracts, and concentrating to obtain a mogroside extract, wherein the concentration of the mogroside extract is 30-40 g / kg.
[0011] Preferably, in step S12, the amount of pectinase added is 0.1-0.15% of the weight of the fresh blueberry fruit, and the amount of cellulase added is 0.05-0.1% of the weight of the fresh blueberry fruit; the enzymolysis time is 3-4 hours; In step S14, the concentration temperature is 30-50°C and the vacuum degree is 0.02-0.04MPa; In step S15, the freeze-vacuum drying temperature is -55 to -65°C, and the vacuum degree is 0.01 to 0.02 MPa.
[0012] Preferably, in step S22, the parameters of the first extraction and the second extraction are the same, and a 60% ethanol solution with a mass-to-liquid ratio of 1: (15-25) is added for extraction, the extraction temperature is 40-50°C, the extraction time is 2-4h, and stirring is performed 3 times, each time for 20min; In step S22, the concentration temperature is 30-50°C and the vacuum degree is 0.02-0.04 MPa.
[0013] Preferably, in step S32, the first leaching is performed by adding purified water with a mass-to-liquid ratio of 1: (10-15), the leaching temperature is 85-95°C, the leaching time is 4-6 hours, and stirring is performed 5 times, each time for 30 minutes; the second leaching is performed by adding purified water with a mass-to-liquid ratio of 1: (5-10), the leaching temperature is 85-95°C, the leaching time is 3-5 hours, and stirring is performed 3 times, each time for 30 minutes; In step S31, the concentration temperature is 50-60°C and the vacuum degree is 0.02-0.04Mpa.
[0014] The second aspect of the present invention provides a method for preparing blueberry ginseng buccal tablets for eye protection and anti-fatigue, comprising the following steps: S1: adding blueberry powder, ginsenoside extract, mogroside extract and hypromellose into a mixer according to the proportion, mixing evenly, using a granulator to granulate, and after drying, using a granulator to granulate; S2: After granulation, magnesium stearate was added, mixed in a mixer, and then tableted using a tablet press to obtain 1 g / tablet blueberry ginseng lozenges.
[0015] Therefore, the present invention adopts the above-mentioned structure of a blueberry ginseng buccal tablet for eye protection and anti-fatigue and a preparation method thereof, which has the following beneficial effects: (1) The present invention has eye protection effect. The high content of blueberry anthocyanidin as one of the core ingredients of the oral tablet ensures that the product has excellent eye protection effect. Anthocyanidin can effectively relieve eye fatigue, improve blurred vision, resist blue light damage, and prevent retinal degeneration and other eye problems. It is especially suitable for people who face computer screens or read for a long time.
[0016] (2) The present invention has an anti-fatigue effect. The ginsenosides Rb1, Rg3, Rg1 and other components in the ginsenoside extract significantly enhance the body's anti-fatigue ability by regulating the function of the nervous system, improve work and study efficiency, and reduce problems such as lack of concentration and memory loss caused by fatigue. At the same time, the addition of momordica saponins further enhances the anti-fatigue effect of the product and helps users quickly recover their physical strength.
[0017] (3) The blueberry of the present invention uses advanced processes such as enzymatic hydrolysis, pressing, dual-effect concentration and freeze-vacuum drying to retain the active ingredients such as anthocyanins in the blueberry to the maximum extent, while removing most of the moisture and undesirable impurities, ensuring the high quality and high purity of the blueberry fruit powder.
[0018] (4) The ginsenosides and momordica grosvenori saponins of the present invention are extracted by alcohol extraction and water extraction respectively, combined with a double-effect concentration process, to effectively extract the active saponin components in ginseng and momordica grosvenori, improve the purity and bioavailability of the extracts, and enable these components to exert better health effects in the buccal tablets.
[0019] (5) The blueberry powder, ginsenoside extract, and mogroside extract in the present invention are prepared in a scientific proportion to form a synergistic mechanism of action, which not only ensures the eye protection and anti-fatigue functions of the product, but also avoids the side effects that may be caused by a single ingredient. The addition of magnesium stearate and hypromellose not only improves the taste and texture of the lozenges, but also improves the stability and compressibility of the product, ensuring quality control during the production process and the uniformity of the finished product.
[0020] (6) The present invention uses natural plants with both medicinal and edible properties, such as blueberry, ginseng, and monk fruit, as raw materials, without adding any artificial coloring, flavoring, or preservatives, thus ensuring the naturalness and safety of the product. At the same time, the natural sugar in blueberry is used as a sweetener, reducing the reliance on exogenous sugar, which is more in line with modern people's pursuit of a healthy diet.
[0021] The technical solution of the present invention is further described in detail below through embodiments. DETAILED DESCRIPTION
[0022] The present invention will be further described below. It should be noted that this embodiment is based on the technical solution and provides a detailed implementation method and a specific operation process, but the present invention is not limited to this embodiment.
[0023] Example 1 A blueberry ginseng buccal tablet for eye protection and anti-fatigue, the buccal tablet comprises the following raw materials in terms of mass percentage: Blueberry powder 46% Ginsenoside extract 25% Monk Fruit Saponin Extract 8% Magnesium stearate 2.3% Hydroxypropyl methylcellulose 18.7%.
[0024] The preparation method of blueberry powder comprises the following steps: S11: Selection of blueberry varieties Select the garden blueberry variety with the highest anthocyanin content as the raw material; S12: Enzymatic hydrolysis After the blueberry fruit was crushed by roller squeezing, pectinase and cellulase were added for enzymolysis at room temperature; the amount of pectinase added was 0.13% of the weight of the blueberry fruit, and the amount of cellulase added was 0.06% of the weight of the blueberry fruit; the enzymolysis time was 3.5h; S13: Squeeze After the enzymatic hydrolysis is completed, the blueberry juice is squeezed by using an air bag squeezer to obtain blueberry juice; S14: Concentrated The blueberry juice is concentrated by using double-effect concentration technology to obtain blueberry concentrated juice; the concentration temperature is 40°C and the vacuum degree is 0.03MPa; S15: Dry The blueberry concentrate is dried into blueberry powder by freeze vacuum drying technology; the freeze vacuum drying temperature is -60°C and the vacuum degree is 0.015Mpa.
[0025] The preparation method of ginsenoside extract comprises the following steps: S21: cutting fresh ginseng into ginseng slices with a thickness of 2 mm using a slicer; S22: putting the ginseng slices into an extraction tank, adding alcohol to extract the ginseng slices for the first time, obtaining an extract, filtering the extract through a 200-mesh filter device, and pumping the extract into a double-effect concentration tank, adding alcohol to the ginseng slices for a second extraction, combining the secondary extracts, and concentrating to obtain a ginsenoside extract, wherein the concentration of the ginsenoside extract is 12.6 g / kg; The parameters of the first and second extractions were the same, and 60% ethanol solution with a mass-to-liquid ratio of 1:20 was added for extraction. The extraction temperature was 45°C, the extraction time was 3 h, and stirring was performed 3 times, each time for 20 min. The concentration temperature is 45°C and the vacuum degree is 0.03MPa.
[0026] The preparation method of the mogroside extract comprises the following steps: S31: crushing the dried monk fruit to obtain coarse powder; S32: adding the coarse powder to an extraction tank, adding water to the extraction tank for a first extraction, filtering the extract through a 200-mesh filter and pumping it into a double-effect concentration tank, adding water to the extraction tank for a second extraction, combining the secondary extracts, and concentrating to obtain a mogroside extract, wherein the concentration of the mogroside extract is 36.4 g / kg; For the first leaching, purified water with a mass-to-liquid ratio of 1:12 was added, the leaching temperature was 90°C, the leaching time was 5 hours, and stirring was performed 5 times, each time for 30 minutes; for the second leaching, purified water with a mass-to-liquid ratio of 1:8 was added, the leaching temperature was 90°C, the leaching time was 3 hours, and stirring was performed 3 times, each time for 30 minutes; The concentration temperature is 55°C and the vacuum degree is 0.03Mpa.
[0027] A method for preparing blueberry ginseng buccal tablets for eye protection and anti-fatigue comprises the following steps: S1: adding blueberry powder, ginsenoside extract, mogroside extract and hypromellose into a mixer according to the proportion, mixing evenly, using a granulator to granulate, and after drying, using a granulator to granulate; S2: After granulation, magnesium stearate was added, mixed in a mixer, and then tableted using a tablet press to obtain 1 g / tablet blueberry ginseng lozenges.
[0028] Comparative Example 1 The difference from Example 1 is that 3% pectinase is added during the preparation of blueberry powder.
[0029] Comparative Example 2 The difference from Example 1 is that 0.2% of cellulase is added during the preparation of blueberry powder.
[0030] Comparative Example 3 The difference from Example 1 is that 80% ethanol aqueous solution is used as the extracting agent during the preparation of the ginsenoside extract.
[0031] Comparative Example 4 The difference from Example 1 is that the extraction temperature during the preparation of the ginsenoside extract is 70°C.
[0032] Comparative Example 5 The difference from Example 1 is that the mass-to-liquid ratio during the preparation of the mogroside extract is 1:25.
[0033] Comparative Example 6 The difference from Example 1 is that the extraction temperature during the preparation of the mogroside extract is 120°C.
[0034] Performance Testing (1) Physical and chemical properties test of lozenges Determination of moisture content of buccal tablets: Weigh 5g of dried, sized granules accurately and record the reading M. Then put them in an oven to dry for a while, cool and weigh them, repeat this step until the difference between the two weighing readings is less than 0.002g, record the final reading, record it as m. Calculate the moisture content according to the formula w = (Mm) / M × 100%.
[0035] Disintegration time of buccal tablets: The finished product was placed in a beaker of a pH=6 aqueous solution and the time required for the complete disintegration of the buccal tablet was measured at a temperature of 37°C.
[0036] Lozenge Stability Analysis: The whole granules were sealed and stored at 50°C away from light. The moisture content of the lozenges was measured on the 3rd day.
[0037] The successfully manufactured tablets were packaged, sealed, and stored at 50°C away from light. The disintegration time of the tablets was measured on the first day.
[0038] The test results are shown in Table 1.
[0039]
[0040] It can be seen from Table 1 that the moisture content of the buccal tablets prepared in Example 1 is about 2.5% to 3%. According to the standard requirements of the Pharmacopoeia, the moisture content in the buccal tablets cannot exceed 9%, so the moisture content of the buccal tablets in Example 1 meets the requirements. The moisture content in the buccal tablets is controlled at about 3% to facilitate tableting, so that the buccal tablets will not stick or crack during the tableting process. The moisture content of the buccal tablets prepared in Comparative Examples 1 to 6 is also about 2.5% to 3%, which meets the requirements. The disintegration time of the buccal tablets in Example 1 is about 28 minutes. According to the disintegration time limit inspection method in Appendix ⅫA of Part I of the 2010 edition of the Chinese Pharmacopoeia, the disintegration time requirement of the buccal tablets should not be completely disintegrated or melted within 10 minutes. The finished buccal tablets produced in Example 1 meet the requirements of the Pharmacopoeia. At the same time, the disintegration time of the buccal tablets prepared in Comparative Examples 1 to 6 is also greater than 10 minutes, which meets the requirements.
[0041] It can also be seen from Table 1 that after the buccal tablets of Example 1 and Comparative Examples 1 to 6 were placed at 50°C (this temperature is higher than the general ambient temperature of 25°C) for 3 days, the moisture content of the buccal tablet of Example 1 was basically unchanged, meeting the pharmacopoeia standard and tablet compression standard, while the moisture content of the buccal tablets of Comparative Examples 1 to 6 was significantly reduced, indicating that the buccal tablets prepared by the present invention have better stability. At the same time, the disintegration time of the buccal tablet of Example 1 did not change significantly, while the disintegration time of Comparative Examples 1 to 6 was significantly reduced, indicating that the buccal tablets prepared by the present invention have good stability.
[0042] (2) Clinical trial testing 280 people aged 15 to 60 who use their eyes for a long time and are prone to visual fatigue were selected as subjects. The double-blind method was used for testing. The subjects were divided into 7 groups, with 40 people in each group. They took the buccal tablets prepared in Example 1 and Comparative Examples 1 to 6, 3 times a day, one tablet each time, and the testing period was 30 days.
[0043] The test subjects were tested for changes in eye wetness before and after taking the lozenges. The test method was: Use tear test filter paper. After closing both eyes, place the test paper into the lower eyelid. After 5 minutes, remove the test paper and observe the length of the test paper wetted by tears.
[0044] The test subjects were tested for their visual field width before and after taking the lozenges. The visual field refers to the spatial range seen when the eyes are fixed straight ahead. It reflects the peripheral visual acuity relative to the central visual acuity. This test used a 3mm diameter white sight mark to check the changes in peripheral visual field. The clarity of the white of the eye and the clarity of the black pupil are also important criteria for judging whether the eyes are healthy. The changes in the clarity of the white of the eye and the clarity of the black pupil of the subject were observed before and after using the eye protection water. The test results are shown in Table 2.
[0045]
[0046] It can be seen from Table 2 that the buccal tablet of Example 1 has a significant improvement effect on eye symptoms, while the buccal tablets prepared in Comparative Examples 1 to 6 have poor improvement on adverse eye symptoms, indicating that the blueberry fruit powder, ginsenoside extract and momordica saponin extract in the present invention have a synergistic enhancement effect and have a good improvement effect on adverse eye symptoms.
[0047] (3) Animal experiments Experimental animals: C57BL / 6 mice, 8 weeks old, male.
[0048] Experimental grouping: 80 mice were divided into a model group and an experimental group (the experimental groups took the buccal tablets prepared in Example 1 and Comparative Examples 1 to 6, respectively), with 10 mice in each group.
[0049] Construction of eye fatigue model: The mice in the model group and the experimental group were exposed to long-term sunlight to simulate eye fatigue. Specifically, incandescent lamps (light intensity of 1000 lux) were used to irradiate the mouse eyes for 12 hours, from 8 am to 8 pm, for 3 days.
[0050] The mice in the normal group were raised according to the normal work and rest and feeding habits. The mice in the model group were irradiated with fluorescent lamps for three days and then raised according to the work and rest and feeding habits of normal mice. In addition to being raised according to the normal work and rest and feeding habits, the mice in the experimental group took 1 / 3 of the buccal tablets prepared in Example 1 and Comparative Examples 1 to 6 at each meal. After taking them for 14 days, the tear secretion and tear film breakup time of the mice were tested.
[0051] Tear secretion test (SIT): This index reflects the amount of tear secretion. The test was performed on the 0th and 14th day after the start of drug administration. The animals were placed in a room with medium brightness and humidity. The Schirmer test paper (5mm×35mm) was folded back at the left end and placed at the junction of the middle and posterior 1 / 3 of the lower eyelid. The animal closed its eyes for 5 minutes and then the paper strip was removed. After drying at room temperature for 30 seconds, the length of the test paper soaked with tears (mm) was measured.
[0052] Tear breakup time (BUT): This index reflects the stability of the tear film. It is measured at 0d and 14d before and after administration. After instillation of fluorescein, the precorneal tear film is observed with a slit lamp. The appearance of black spots indicates tear film breakup, and the time until dry spots appear is the BUT value.
[0053] The results of animal experiments are shown in Table 3.
[0054]
[0055] As can be seen from Table 3, compared with the buccal tablets prepared in Comparative Examples 1 to 6, the buccal tablets prepared in Example 1 have significantly increased tear secretion and prolonged tear film breakup time after taking them for 14 days. The results show that the buccal tablets prepared in the present invention can play a synergistic role and more effectively improve adverse eye symptoms, thereby increasing tear secretion and stabilizing the tear film.
[0056] Therefore, the present invention adopts the above-mentioned structure to provide an eye-protecting and anti-fatigue blueberry ginseng lozenge and a preparation method thereof. Raw materials such as blueberry fruit powder, ginsenoside extract, and momordica grosvenori saponin extract are combined in a scientific proportion to form a synergistic mechanism of action, which not only ensures the eye-protecting and anti-fatigue functions of the product, but also avoids the side effects that may be caused by a single ingredient.
[0057] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that they can still modify or replace the technical solution of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solution to deviate from the spirit and scope of the technical solution of the present invention.
Claims
1. A blueberry ginseng lozenge for eye protection and anti-fatigue, It is characterized in that The buccal tablets include the following raw materials according to mass percentage: Blueberry powder 30~50% Ginsenoside extract 20~30% Momordica Saponin Extract 5~10% Magnesium stearate 2~5% Hydroxypropyl methylcellulose 15~25%.
2. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 1, It is characterized in that The preparation method of blueberry powder comprises the following steps: S11: Selection of blueberry varieties Select the garden blueberry variety with the highest anthocyanin content as the raw material; S12: Enzymatic hydrolysis Fresh blueberries are crushed by roller squeezing, and then pectinase and cellulase are added for enzymatic hydrolysis at room temperature. S13: Squeeze After the enzymatic hydrolysis is completed, the blueberry juice is squeezed by using an air bag squeezer; S14: Concentrated The blueberry juice is concentrated by using double-effect concentration technology to obtain blueberry concentrated juice; S15: Dry The blueberry concentrate is dried into blueberry fruit powder using freeze vacuum drying technology.
3. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 1, It is characterized in that The preparation method of ginsenoside extract comprises the following steps: S21: cutting the fresh ginseng into ginseng slices with a thickness of 1-3 mm using a slicer; S22: Put the ginseng slices into an extraction tank, add alcohol to extract the ginseng slices for the first time, and obtain an extract. After the extract is filtered through a 200-mesh filter, it is pumped into a double-effect concentration tank, and the ginseng slices are again added with alcohol for a second extraction. The secondary extracts are combined and concentrated to obtain a ginsenoside extract. The concentration of the ginsenoside extract is 10-15 g / kg.
4. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 1, It is characterized in that The preparation method of the mogroside extract comprises the following steps: S31: crushing the dried monk fruit to obtain coarse powder; S32: adding the coarse powder to an extraction tank, adding water to the extraction tank for the first extraction, filtering the extract through a 200-mesh filter and pumping it into a double-effect concentration tank, adding water to the extraction tank for the second extraction, combining the secondary extracts, and concentrating to obtain a mogroside extract, wherein the concentration of the mogroside extract is 30-40 g / kg.
5. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 2, It is characterized in that In step S12, the amount of pectinase added is 0.1-0.15% of the weight of the fresh blueberry fruit, and the amount of cellulase added is 0.05-0.1% of the weight of the fresh blueberry fruit; the enzymolysis time is 3-4 hours; In step S14, the concentration temperature is 30-50°C and the vacuum degree is 0.02-0.04 MPa; In step S15, the freeze-vacuum drying temperature is -55 to -65°C, and the vacuum degree is 0.01 to 0.02 MPa.
6. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 3, It is characterized in that In step S22, the parameters of the first extraction and the second extraction are the same, and a 60% ethanol solution with a mass-to-liquid ratio of 1: (15-25) is added for extraction, the extraction temperature is 40-50°C, the extraction time is 2-4h, and stirring is performed 3 times, each time for 20min; In step S22, the concentration temperature is 30-50°C and the vacuum degree is 0.02-0.04 MPa.
7. The blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 4, It is characterized in that In step S32, the first leaching is performed by adding purified water with a mass-to-liquid ratio of 1: (10-15), the leaching temperature is 85-95°C, the leaching time is 4-6 hours, and stirring is performed 5 times, each time for 30 minutes; the second leaching is performed by adding purified water with a mass-to-liquid ratio of 1: (5-10), the leaching temperature is 85-95°C, the leaching time is 3-5 hours, and stirring is performed 3 times, each time for 30 minutes; In step S31, the concentration temperature is 50-60°C and the vacuum degree is 0.02-0.04Mpa.
8. The method for preparing the blueberry ginseng buccal tablet for eye protection and anti-fatigue according to claim 1, It is characterized in that The following steps are involved: S1: adding blueberry powder, ginsenoside extract, mogroside extract and hypromellose into a mixer according to the proportion, mixing evenly, using a granulator to granulate, and after drying, using a granulator to granulate; S2: After granulation, magnesium stearate was added, mixed in a mixer, and then tableted using a tablet press to obtain 1 g / tablet blueberry ginseng lozenges.
